Cargando…

Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer

OBJECTIVES: We sought to determine the impact of pretreatment plasma platelet levels, dimerized plasmin fragment (D-dimer) and fibrinogen in recurrent epithelial ovarian cancer (EOC) and the impact of platelet levels on SKOV3 cell lines growth and responsiveness to chemotherapy. METHODS: Under appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qinghong, Hada, Abha, Han, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368983/ https://www.ncbi.nlm.nih.gov/pubmed/32682445 http://dx.doi.org/10.1186/s13048-020-00682-z

Ejemplares similares

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Afatinib use in recurrent epithelial ovarian carcinoma
por: Shepherd-Littlejohn, Amanda L., et al.
Publicado: (2019)

Correlation of percentage changes in platelet counts with recurrence rate following radical nephrectomy
por: Patel, A., et al.
Publicado: (2010)

Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
por: Zhao, Ling-Qin, et al.
Publicado: (2022)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
por: Hoffmann, Oliver Ingo, et al.
Publicado: (2022)

Palbociclib in the treatment of recurrent ovarian cancer
por: Lee, Dai Wee, et al.
Publicado: (2020)

Dermatomyositis - key to diagnosing ovarian cancer, monitoring treatment and detecting recurrent disease: Case report
por: Field, Carlie, et al.
Publicado: (2017)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
por: Hirose, Sou, et al.
Publicado: (2018)

The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review
por: Roche, Michael, et al.
Publicado: (2018)

Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment
por: Choi, Noorie, et al.
Publicado: (2017)

Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
por: Hung, Jo-Ni, et al.
Publicado: (2022)

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma
por: Hu, Jun, et al.
Publicado: (2020)

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience
por: Moubarak, Malak, et al.
Publicado: (2022)

Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma
por: Vaios, Eugene J, et al.
Publicado: (2020)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

Intra-platelet Serotonin as a Biomarker in HCC Recurrence: When Time Matters
por: Aryal, Bibek, et al.
Publicado: (2019)

Treatment for Recurrent Ovarian Cancer—At First Relapse
por: Ushijima, Kimio
Publicado: (2010)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
por: White, N M A, et al.
Publicado: (2009)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
por: Gui, Ting, et al.
Publicado: (2014)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
por: Zhang, Zhengmao, et al.
Publicado: (2019)

Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
por: Okunade, Kehinde Sharafadeen, et al.
Publicado: (2020)

Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma
por: Ye, Jing, et al.
Publicado: (2020)

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
por: Xia, Weiliang, et al.
Publicado: (2015)

Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
por: Rhone, Piotr, et al.
Publicado: (2019)

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
por: Lu, Zhan, et al.
Publicado: (2023)

Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy
por: Wacharachawana, Sornsittipong, et al.
Publicado: (2021)

Identification of Metabolic Biomarkers Using Serial (18)F–FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2017)

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
por: Sumi, Natalia J., et al.
Publicado: (2014)

Oophoropexy for Recurrent Ovarian Torsion
por: Hartley, Jennifer, et al.
Publicado: (2018)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Individualized treatment for a case of recurrent ovarian ependymoma
por: Yuan, Zhen, et al.
Publicado: (2018)

Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
por: Hosono, S, et al.
Publicado: (2007)

Analysis and Comparison of Somatic Mutations in Paired Primary and Recurrent Epithelial Ovarian Cancer Samples
por: Kim, Yong-Man, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_08etou02pvamibphe3uvf08vdn